Publications
Genomics of Immune Cells
Total number of publications: 290
2025
-
HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapy
Leukemia, year: 2025, volume: 39, edition: 6, DOI
-
Hypomethylating agents increase L1 retroelement expression without inducing novel insertions in myeloid malignancies
Molecular oncology, year: 2025, volume: 19, edition: 10, DOI
-
In Reply: MicroRNA Analysis in Meningiomas With Different Degrees of Tissue Stiffness: A Potential Tool for Effective Preoperative Planning
Neurosurgery, year: 2025, volume: 97, edition: 2, DOI
-
Incidental Germline Findings During Comprehensive Genomic Profiling of Pancreatic and Colorectal Cancer: Single-center, Molecular Tumor Board Experience
Mutagenesis, year: 2025, volume: 40, edition: 1, DOI
-
In-frame germline TP53 variant impairs p53 oligomerization and predisposes to cancer
Nature Scientific Reports, year: 2025, volume: 15, edition: 1, DOI
-
Komentář k operativnímu postupu NIKEZ - Algoritmus diagnostiky maligní hypertermie v České republice, praktické konsekvence
Anesteziologie a intenzivní medicína, year: 2025, volume: 36, edition: 2, DOI
-
MicroRNA Analysis in Meningiomas with Different Degrees of Tissue Stiffness: A Potential Tool for Effective Preoperative Planning
Neurosurgery, year: 2025, volume: 96, edition: 5, DOI
-
MicroRNA Profiling of Bone Marrow Plasma Extracellular Vesicles in Multiple Myeloma, Extramedullary Disease, and Plasma Cell Leukemia
Hematological Oncology, year: 2025, volume: 43, edition: 1, DOI
-
PEDIATRIC ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA GENETICALLY DIFFERS FROM THE ADULT COUNTERPART
Leukemia Research, year: 2025, volume: 156, edition: NA, DOI
-
Precizní medicína v hematoonkologii - léčba refrakterního mnohočetného myelomu s masivním extramedulárním postižením BRAF/MEK inhibitory
Klinická onkologie, year: 2025, volume: 38, edition: 5, DOI